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Abstract
Background: Hemorrhagic fever with renal syndrome (HFRS) caused by pathogenic hantaviruses in Europe and
Asia is often characterized by acute kidney injury (AKI) with massive proteinuria. Renal filtration depends on the
integrity of epithelial and endothelial monolayers in the tubular and glomerular apparatus. Tubular and glomerular
cells represent target cells of hantavirus infection. However, the detailed mechanisms of renal impairment induced
by hantaviruses are not well understood.
Methods: We analyzed the cellular consequences of hantavirus infection by measuring adhesion and migration
capacity of human renal cells infected with Puumala (PUUV) or Hantaan (HTNV) virus. The impact of hantaviral
nucleocapsid proteins (N proteins) on motility was examined by transfection of podocytes.
Results: Infection of kidney cells with hantavirus species PUUV and HTNV causes a significant reduction of
migration capacity. The impaired motility depends on viral replication and transfection of podocytes with N protein
of PUUV or HTNV reveals that the expression of N protein alone is sufficient to deteriorate podocyte function. The
cellular effects are more pronounced for the more pathogenic HTNV than for PUUV that causes a milder form of
HFRS.
Conclusions: The direct impairment of migration capacity of renal cells by hantaviral N proteins may contribute
substantially to proteinuria observed in the clinical picture of hantavirus infection.
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Background
Hantaviruses are distributed worldwide and among the
emerging pathogens that attract the attention of kidney
research due to increasing numbers of cases and due to
identification of novel species with pathogenic potential
to humans [1]. HFRS varies considerably in its
symptoms and severity depending on the causative virus
species. Severe infections with hantaviruses HTNV,
Dobrava-Belgrade virus (DOBV), or PUUV are charac-
terized by AKI with massive proteinuria. The proteinuria
is non-selective indicating that glomerular and tubular
structures are affected [2]. Moreover, immunofluores-
cence and electron microscopy studies demonstrate
tubular and glomerular changes in renal specimens of
patients with hantavirus infection [3–5].
The glomerular filtration barrier mainly exerts its
function via three layers: fenestrated endothelium,
glomerular basement membrane (GBM), and podocytes.
Normal kidney filter function depends on the integrity
of GBM and of tubular and glomerular monolayers. Cell
adhesion and individual cell motility play a pivotal role
in the establishment and maintenance of cell-to-cell
contacts, polarity, and renal filtration. Cytoskeletal alter-
ations are characteristic for many renal diseases and
changes in motility correlate with proteinuria [6–8].
Glomerular proteinuria is predictive for the severity of
hantavirus-induced AKI [9]. The infection of renal cells
by hantaviruses may contribute to proteinuria and may
represent a determinant in the clinical course of HFRS.
Hantaviral N protein was detected in tubular and glom-
erular cells and cell-to-cell contact structures were chan-
ged in biopsy samples of patients with serologically
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However, the underlying mechanisms and effects of
hantavirus infection on human renal cells have not been
investigated so far. To identify the consequences of
hantavirus infection, we analyzed adhesion and motility
capacity of human renal cells infected with hantaviruses
PUUV or HTNV.
Methods
Cells
Primary podocytes (Lonza) were maintained in RPMI
medium (Capricorn) supplemented with 10% fetal calf
serum (FCS). Human renal epithelial cells (HREpCs)
(PromoCell) were cultured in renal epithelial cell growth
medium-2 (PromoCell). Human renal glomerular endo-
thelial cells (HRGEnC) (ScienCell) were maintained in
endothelial cell medium ECM (ScienCell). Primary cells
were only used from passage two to six. The human podo-
cyte cell line was derived from human normal podocytes
conditionally transformed with a temperature-sensitive
mutant of the simian virus 40 (SV40) large T antigen. Cells
were cultured as previously described [10]. Experiments
were performed with non-proliferating, differentiated
podocytes expressing synaptopodin as podocyte-specific
marker of differentiation. Vero E6 cells were maintained
in DMEM (Capricorn) supplemented with 10% FCS.
Viruses and infection
Hantavirus species HTNV strain 76–118 and PUUV
strain Vranica were propagated on Vero E6 cells. For
infection, cells were incubated with viral inocula at a
multiplicity of infection (MOI) of 0.5 and medium was
replaced after six hours. MOI was calculated on the
respective cell type. On day six after infection, infected
cells were quantified by detection of N protein expres-
sion via immunofluorescence staining and subjected to
the assays.
Human sera samples
Heat-inactivated (56 °C, 30 min) serum samples of three
healthy volunteers and three patients with serologically
confirmed PUUV infection were used for incubation of
podocytes in migration assays. Semiquantitative protein-
uria was determined by urine dipstick: +: 30 mg/dL, ++:
100 mg/dL, +++: 300mg/dL, and ++++: 1000mg/dL.
Clinical data were collected through a review of medical
charts of the Department of Nephrology of the Univer-
sity of Heidelberg, Germany. This study was approved
by the Ethics Committee of the University of Heidelberg
and it adhered to the Declaration of Helsinki. Written
informed consent was obtained from all participants.
Immunofluorescence (IF)
Cells grown on coverslips were fixed with 3% para-
formaldehyde (PFA) and stained with primary and
fluorescently-labeled secondary antibodies. The follow-
ing primary antibodies were used: Mouse anti-N protein
PUUV (A1C5, Progen), mouse anti-N protein HTNV
(B5D9, Progen). Cell nuclei were stained by Hoechst
33342 (Invitrogen). Images were taken using an Axiocam
506 mono camera attached to an Axio Observer.D1
inverted microscope (Carl Zeiss).
Western blot
For Western blot analysis, samples were boiled in SDS
sample buffer, separated by SDS-PAGE, and transferred
to a nitrocellulose membrane. Membranes were blocked
with 5% nonfat dried milk in Tris-buffered saline
containing 0.1% Tween20 (TBST) for 30 min at room
temperature and then incubated for one hour at room
temperature with the following antibodies: Mouse
anti-N protein PUUV (A1C5, Progen), mouse anti-N
protein HTNV (B5D9, Progen). After washing with
TBST, the membrane was incubated with near-infrared
fluorescently-labeled anti-mouse secondary antibodies
(IRDye800, Li-Cor) for one hour at room temperature.
After washing with TBST, the membrane was scanned
by the Odyssey CLx infrared imaging system (Li-Cor).
Treatment of viral supernatants
Infectious hantaviral particles in supernatants derived
from infected podocytes on day six after infection were
inactivated by UV irradiation (1.4 J/cm2) with Stratalinker
UV Crosslinker equipped with 254 nm UV-light bulbs or
depleted by filtration at 5000 g at 4 °C for 2 h through
Nanosep centrifugal device with Omega membrane 300 K
(Pall Life Sciences) with a molecular weight cut-off of 300
kDa [11].
Transfection of cells
Podocytes were transfected with pmaxGFP encoding
green fluorescent protein (Lonza) together with pCR3.1
(Invitrogen) encoding full-length N protein of PUUV or
HTNV using nucleofection (Amaxa Nucleofector 2b de-
vice, Lonza) with the Basic Nucleofector Kit for primary
mammalian epithelial cells (Lonza). Transfection of
pmaxGFP together with empty vector (mock) served as
control. After eight hours, cells were subjected to live
cell imaging or immunofluorescence. All cells expressing
maxGFP co-expressed hantaviral N protein. Percentage
and viability of cells expressing max GFP together with
N protein did not differ compared to cells transfected
with pmaxGFP and empty vector. Amount of N protein
expression was quantified by determination of the fluor-
escence levels of 100 transfected cells that were stained
for N protein with anti-N protein antibody. Area, mean
fluorescence signal, and adjacent background readings
were measured for each cell using ImageJ (v1.52e, NIH).
The fluorescence levels were calculated with ImageJ as
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total corrected cell fluorescence (TCCF) of N protein
(TCCF = integrated density – (area of selected cell ×
mean background fluorescence)) [12].
Viability assay
Uninfected and infected cells were lysed on day six after
infection. The number of viable cells was determined by
measuring the amount of ATP using CellTiter-Glo
luminescent cell viability assay (Promega).
Live cell imaging and single cell tracking
Infected and transfected cells (10,000 cells/cm2) on
μ-slide 2-wells (Ibidi) were subjected to live cell imaging.
The motility of infected and uninfected podocytes was
monitored for eight hours by JuLi Smart Fluorescence
Cell Imager (Digital-Bio). Cells were tracked by the
ImageJ manual tracking plugin (Ibidi) and statistical
analysis was done by using the chemotaxis tool plugin
(Ibidi). The migration of podocytes co-transfected with N
protein together with green fluorescent protein (maxGFP;
Lonza) was recorded using a Ti-HCS microscope with an
Andor Clara interline-CCD-camera (Nikon). Cells ex-
pressing maxGFP were tracked and analyzed as described
for infected cells.
Migration assay
Podocytes (45,000 cells/cm2) were seeded into μ-plate
wells (Ibidi) and infected with hantaviruses. The insert
was removed six days after infection and images were
taken immediately after insert removal and after eight
hours by JuLi Smart Fluorescence Cell Imager (Digital
Bio). The average area of migrated cells was measured
in three independent experiments. Cells were fixed
with 3% PFA and stained for nuclei and hantaviral N
protein.
Fig. 1 Motility of PUUV-infected human primary HREpCs, HRGEnCs, and podocytes. a Infection of renal cells with PUUV. Cells were infected with
PUUV at an MOI of 0.5 for six days and stained for hantaviral N protein (red) and nuclei (blue). Cells were imaged at a magnification of × 200.
b Quantification of infection by detection of N protein expression. c Migration of uninfected and infected human primary renal cells was
analyzed by single cell tracking via live cell imaging on day six after infection. Three independent experiments were performed. In each single cell
tracking experiment 30 cells were analyzed. Shown is mean ± SD
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Adhesion assay
Uninfected or infected podocytes of a single-cell suspen-
sion (29,000 cells/cm2) were added in each well of a
96-well microtiter plate and left to adhere for one hour
at 37 °C. After a triple wash with PBS, adhered cells were
fixed, and stained with Sapphire700 (Li-Cor) and
DRAQ5 (BioStatus) and quantified via scanning with
Odyssey CLx infrared imaging system (Li-Cor).
Statistical analysis
Data were analyzed using Prism 5.0 (GraphPad Software
Inc.). Normal distribution was tested with the
Kolmogorov-Smirnov test. Values of two groups were
compared using two-tailed Student’s t-test. Values were
presented as mean ± standard deviation (SD). P values
of ≤0.05 were considered significant. *P ≤ 0.05; **P ≤ 0.01;
***P ≤ 0.001; ****P ≤ 0.0001; ns: not significant.
Results
Migration capacity of PUUV-infected human primary
renal cells
To analyze if hantavirus infection interferes with renal cell
function, we measured the motility of PUUV-infected pri-
mary HREpCs, HRGEnCs, and human primary podocytes
by single cell tracking. Infection was monitored by immu-
nostaining for N protein revealing that more than 90% of
cells were positive for PUUV N protein (Fig. 1a and b).
Infection of human primary tubular (HREpCs) and
glomerular (HRGEnCs and podocytes) cells resulted
in an impaired migration capacity as revealed by
single cell tracking (Fig. 1c). Motility of infected tubu-
lar epithelial cells was reduced to 58.65% ± 2.87%
compared to uninfected HREpCs (100% ± 3.05%; P =
0.0006). In glomerular cells the levels were reduced
to 79.48% ± 1.43% vs. 100% ± 4.86%; P = 0.0154 and to
Fig. 2 Functional consequences of PUUV-infection in human podocytes. a Podocytes were infected with PUUV at an MOI of 0.5 and viability was
assessed on day six post infection. Control cells remained uninfected and viability was set to 100%. Three independent experiments were
performed in triplicates. Shown is mean ± SD. b Migration of uninfected and infected podocytes was analyzed by single cell tracking via live cell
imaging. Three independent experiments were performed. In each experiment 30 cells were analyzed. Shown is mean ± SD. c For migration
assay, podocytes were seeded into μ-plate wells and infected with PUUV at an MOI of 0.5 for six days. After removal of the insert and after eight
hours, cell-free areas were measured and relative migration was calculated. Migration of uninfected podocytes was set to 100%. Representative
images are shown. Nuclei were stained in blue, N protein in red. Cells were imaged at a magnification of × 100. Three independent experiments
were performed. Shown is mean ± SD. d Adhesion of PUUV-infected cells. Uninfected and PUUV-infected podocytes were plated into 96 wells
and numbers of attached cells were quantified after one hour. Nuclei were stained in blue, N protein in red. Cells were imaged at a magnification
of × 200. Adhesion of uninfected cells was set to 100%. Results were obtained from three independent experiments, each performed in
quadruplicate. Shown is mean ± SD
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65.66% ± 3.76% vs. 100% ± 3.97%; P = 0.0033 for
HRGEnCs and podocytes, respectively.
Migration and adhesion capacity of PUUV- infected
podocytes
Using a human podocyte cell line, we studied the func-
tional consequences of hantavirus infection of renal cells
in more detail. We tested the viability of podocytes after
infection with PUUV (Fig. 2a). Quantification of infected
cells by immunofluorescence of N protein revealed
that 93.19% ± 2.29% of cells were infected with PUUV.
The infection had no effect on viability. Motility was
also analyzed for the PUUV-infected podocyte cell
line (Figs 2b and c). The distance covered by infected
podocytes was reduced to 73.35% ± 4.24% compared
to uninfected cells (100% ± 3.06%; P = 0.0003). Meas-
uring cell-free areas by migration assays revealed a
migration capacity of infected monolayers that was
reduced to 72.80% ± 4.89% vs. 100% ± 11.06%; P =
0.0041. In addition, we examined the adhesion of in-
fected cells (Fig. 2d). After infection, the number of
adherent cells was decreased to 70.96% ± 7.88% vs.
100% ± 15.53%; P = 0.0446.
Migration and adhesion capacity of HTNV- infected
podocytes
To investigate whether the effects on podocytes are
related to other pathogenic Old World hantaviruses, we
examined the infection of podocytes with HTNV (Fig. 3).
Quantification of infected cells by immunofluores-
cence of N protein revealed that 91.76% ± 1.37% of
cells were infected with HTNV. Viability of podocytes
was not influenced by HTNV infection (Fig. 3a).
Motility was impaired compared to uninfected
Fig. 3 Functional consequences of HTNV-infection in human podocytes. a Podocytes were infected with HTNV at an MOI of 0.5 and viability was
assessed on day six post infection. Control cells remained uninfected and viability was set to 100%. Three independent experiments were
performed in triplicates. Shown is mean ± SD. b Motility of uninfected and infected podocytes was analyzed by single cell tracking via live cell
imaging. Three independent experiments were performed. In each experiment 30 cells were analyzed. Shown is mean ± SD. c Podocytes seeded
into μ-plate wells were infected with HTNV and analyzed by migration assay after six days after infection. After removal of the insert and after
eight hours, cell-free areas were measured and relative migration was calculated. Migration of uninfected podocytes was set to 100%.
Representative images are shown. Cells were imaged at a magnification of × 100. Three independent experiments were performed. Shown is
mean ± SD. d Uninfected and HTNV-infected cells were plated into 96 wells and numbers of attached cells were quantified after one hour.
Results were obtained from three independent experiments, each performed in quadruplicate. N protein was stained in red. Cells were imaged at
a magnification of × 200. Adhesion of uninfected cells was set to 100%. Shown is mean ± SD
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podocytes (Fig. 3b and c). The distance covered by
HTNV-infected podocytes was reduced to 40.02% ±
1.92% vs. 100% ± 2.21%; P < 0.0001 and migration of
infected monolayers was decreased to 27.49% ± 10.69%
vs. 100% ± 9.29%; P = 0.0009. Adhesion capacity was
also reduced in HTNV-infected podocytes (57.13% ±
16.28% vs. 100% ± 15.7%; P = 0.0304) (Fig. 3d). The
HTNV-mediated deterioration of podocyte functions
was more pronounced than the effects caused by
PUUV infection.
Migration of podocytes incubated with culture
supernatants and sera
Next, we examined whether viral replication is required
for the impairment of migration (Fig. 4). To inactivate or
deplete infectious PUUV and HTNV particles, superna-
tants were UV-treated or filtrated. Inactivation and re-
moval of infectious particles were controlled by Western
blot analysis of N protein and by inoculation of Vero E6
cells (Fig. 4a and c). N protein was no longer detected in
the filtrates and no infection was observed in Vero E6
Fig. 4 Motility of podocytes incubated with supernatants of infected podocytes. a Untreated, UV-irradiated, and filtrated supernatants of
podocytes infected with PUUV for six days at an MOI of 0.5 were analyzed for the presence of N protein by Western blot and for infectivity via
incubation of Vero E6 cells and subsequent detection of N protein (red). Cells were imaged at a magnification of × 200. b Supernatants and
filtrates were added to uninfected podocytes 30min before migration assay. Migration assay was performed in the presence of supernatants and
filtrates and analyzed as described in Fig. 2c. Migration of podocytes in the presence of untreated, UV-irradiated, and filtrated supernatants of
uninfected podocytes served as control (ctrl) and was set to 100%. (c and d) Supernatants of HTNV-infected podocytes were treated and
analyzed as described for PUUV in (a and (b). (e and f) Time course of infection and motility analyzed in podocytes inoculated with untreated
supernatants derived from HTNV-infected podocytes after six days of infection. e Infection was quantified by counting cells expressing N protein
at the indicated time points. f Migration assays were started after 30 min of incubation with supernatant and motility was analyzed at the
indicated time points. Untreated supernatants of uninfected podocytes served as control (ctrl) and was set to 100%. Results were obtained from
three independent experiments. Shown is mean ± SD
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cells incubated with UV-irradiated or filtrated superna-
tants. Migration assays with podocytes inoculated with
supernatants derived from HTNV-infected podocytes re-
vealed that migration capacity is reduced in the presence
of infectious particles. In contrast, incubation with su-
pernatants containing UV-inactivated particles or with
filtrated supernatants did not change the migration of
uninfected podocytes. No significant effect was observed
in samples inoculated with supernatant derived from
PUUV-infected podocytes (Fig. 4b and d). Quantification
of infection in podocytes incubated with untreated su-
pernatants by detection of N protein after migration
assay, revealed that 33.48% ± 6.74% of cells were infected
with HTNV and 4.51% ± 3.72% with PUUV after 8.5 h of
incubation. The high percentage of HTNV-infected cells
may account for the decrease in motility. Therefore, the
hantavirus-mediated impairment of podocyte migration
depends on viral replication. We examined the levels of
infection and decrease of motility at earlier time points
after incubation with untreated supernatants collected
from HTNV-infected podocytes. 30.20% ± 9.31% of cells
were infected at 4.5 h after adding supernatants and the
motility was decreased to 69.81% ± 9.32% (Fig. 4e and f).
Levels of infected cells and motility impairment did not
change over time. The effect is observed very early after
infection and does not depend on viral spread.
We analyzed whether circulating factors affecting
podocyte function were present in the serum of patients
with acute PUUV hantavirus infection (Table 1, Fig. 5).
The patients showed characteristic clinical symptoms
(sudden onset of flu-like symptoms), impairment of la-
boratory parameters (thrombocytopenia, rise in levels of
serum creatinine, leukocytes, LDH, CRP, and low levels
of serum albumin), proteinuria, and hematuria. Sera
samples of the three patients were collected during the
clinical course and subjected to migration assays with
uninfected podocytes in vitro. Figure 5 shows the course
of serum creatinine levels of patients and the migration
capacity of podocytes incubated with sera collected at
the indicated time points. None of the seven sera sam-
pled at different phases of the clinical course of the three
patients demonstrated any impact on the migration of
podocytes compared to sera of healthy control individ-
uals or normal cell culture medium. Podocytes incu-
bated with sera from infected patients were not infected
as revealed by immunofluorescence analysis of N protein
expression (data not shown).
Functional consequences of hantaviral N protein expression
The multifunctional hantaviral N protein is the most
abundant protein early in infection [13]. Therefore, we
wanted to investigate if the expression of N protein is suf-
ficient to induce impairment of podocyte function. We
performed single cell tracking of N protein-transfected
podocytes by live cell microscopy (Fig. 6). The motility
analysis of podocytes expressing recombinant N
proteins revealed a reduction of the covered distance to
46.92% ± 8.85%; P = 0.0017 for HTNV and to 72.90% ±
7.22%; P = 0.0134 for PUUV compared to
mock-transfected cells (100% ± 8.45%) (Fig. 6a). Despite
equal expression levels of HTNV and PUUV N protein
as revealed by determination of fluorescence intensity
(Fig. 6b), the effect on podocyte motility was less pro-
nounced for PUUV N protein. Interestingly, the trans-
fection of N protein results in a reduction of motility
capacity that is exactly the same level as observed in in-
fection with the respective virus species (Figs. 2b, 3b):
the motility of podocytes infected with HTNV was re-
duced to 40.02% ± 1.92% and motility of podocytes
transfected with HTNV N protein was decreased to
46.92% ± 8.85% (P = 0.2092). Podocytes infected with
PUUV exhibited a reduced motility of 73.35% ± 4.24%
and motility of podocytes expressing PUUV N protein
was reduced to 72.90% ± 7.22% (P = 0.7876).
Table 1 Characteristics and laboratory parameters of three patients with acute PUUV HFRSa
#64 #176 #211 Reference
Age (years) 37 53 25
Gender m m m
Duration of hospitalization (days) 8 15 10
Max serum creatinine level (mg/dL) 11.94 (9) 12.16 (10) 10.89 (7) 0.1–1.3
Min serum albumin level (g/L) 28 (3) 31 (7) 31.1 (8) 30–50
Max leukocyte count (109/L) 15.6 (3) 15.73 (5) 7.57 (4) 4–10
Min platelet count (109/L) 65 (2) 52 (3) 49 (3) 150–440
Max LDH activity (U/L) 329 (8) 405 (8) 422 (4) < 248
Max CRP level (mg/L) 94.5 (2) 143.7 (3) 61.2 (4) < 5
Urine dipstick protein +++ (2) +++ (7) ++++ (4) –
Urinary erythrocyte count (/μL) 25 (3) 69 (3) 43 (5) 0
anumbers in brackets indicate the days post onset
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Together, these results demonstrate that the expres-
sion of hantaviral N proteins alone is sufficient to induce
impairment of podocyte motility in a virus-specific
manner.
Discussion
Damage to host organisms by pathogens may indirectly
occur via the immune system and/or directly due to
interference with cellular processes during their replica-
tion cycle. The direct effects are often cell type-specific
and mediated by modulation of structural components
or interference with signaling pathways of the host cell.
Hantaviruses infect different organs and cell types. Cells
of the respiratory tract, of the kidney, and of the
immune system have been described to be susceptible to
hantavirus infection [3, 14–17]. In most cases of infec-
tions with Old World hantaviruses, renal involvement
dominates and leads to AKI, proteinuria, and microhe-
maturia. The underlying molecular and cellular mecha-
nisms in the pathogenesis of AKI and leakage are not
completely understood. Direct effects observed in in-
fected renal cells such as disruption of cell-to-cell con-
tacts and alterations in motility and adhesion contribute
to proteinuria. However, the role of direct infection of
target cells in the failure of organs in HCPS and HFRS
needs to be further investigated.
We demonstrate that hantaviruses disturb cellular
function of human primary renal cells that may result in
proteinuria. Infection of both, tubular and glomerular
cell types, leads to severe alterations in motility. The
expression of hantaviral N protein alone is sufficient to
impair migration. N protein may represent a pathogen-
icity factor of hantavirus-induced proteinuria. An associ-
ation of structural changes and hantaviral N protein
expression has also been described in tubules of patients
with acute hantavirus infection [3].
Neither non-infectious supernatants derived from in-
fected podocytes nor sera from patients with hantavirus
infection exhibit any effect on podocytes in vitro. There-
fore, viral replication is required to impair cellular motil-
ity. In addition, local effects of soluble factors released
by renal or immune cells may contribute to the clinical
course in vivo. It is also possible that infection sensitizes
renal cells to soluble factors, as it is described for
hantavirus-infected HUVECs and VEGF [18]. Cytokines
may act on these cells and contribute or counteract to
motility alterations. Several signal cascades have been
described to be involved in the regulation of podocyte
function: vascular endothelial growth factor (VEGF),
urokinase plasminogen activator receptor (uPAR), or
interleukin-6 (IL-6) are modulators of podocyte signaling
[7, 19, 20]. Interestingly, these mediators are also known
to be up-regulated in hantavirus infection [21–24]. In
cells sensitized by infection, these effectors may
Fig. 5 Migration of podocytes inoculated with sera of patients with
PUUV infection. Podocytes were inoculated with normal podocyte
medium containing 10% FCS (−, white bars), medium containing
50% serum of healthy control individuals (ctrl, light grey bars), or
with medium containing 50% serum of patients with PUUV infection
collected during the clinical course (dark grey bars) and analyzed by
migration assay. Sera were added 30 min before insert removal.
Averaged migration of podocytes in the presence of sera derived
from three healthy donors was set to 100%. Shown is mean ± SD.
Levels of patients’ serum creatinine were shown on the right y-axis
to monitor the clinical course of infection. Dashed horizontal line
indicates the reference value of serum creatinine for healthy
individuals. Dpo: days post onset
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contribute or counteract to the impairment of motility
mediated by N protein expression. Further studies are
necessary to resolve the role of direct and indirect effects
of hantavirus infection in the balance of podocyte motil-
ity and transient proteinuria.
The functional consequences of infection and N
protein expression were more pronounced for HTNV
than for PUUV. These observations from in vitro experi-
ments correspond to the clinical picture of PUUV- and
HTNV-induced HFRS with HTNV being the more
pathogenic virus species [25]. However, it remains to
examine if the observed cellular effects of renal infection
contribute to the severity of the clinical course of PUUV
and HTNV infection. The underlying mechanisms for
differences in hantaviral pathogenicity are not fully
understood. Analysis of reassortants between the weakly
pathogenic DOBV-Aa subtype and the highly virulent
subtype DOBV-Af revealed that characteristics concerning
induction of the innate immune system in host cells are
determined by the segments encoding for N protein and
RNA-dependent RNA polymerase [26]. Studies with New
World hantavirus Andes virus (ANDV) indicated that the
N protein of ANDV interferes with signaling cascades of
the innate immune system [27, 28]. Gorbunova et al.
demonstrated that the ANDV N protein enhances perme-
ability of microvascular endothelial cells via activation of
RhoA [29]. These findings and our results show that N
proteins of New and Old World hantaviruses interfere
with cellular signaling and function and may act as a
pathogenicity factor in hantavirus infection.
Hantaviral N proteins share high homology between
species and it would be of great interest to identify N
protein-specific characteristics responsible for the
differences in the functional outcome. Future work
will focus on the mode of interaction of different
hantaviral N proteins with specific target cells. The
analysis of the underlying mechanisms of N
protein-induced cellular alterations will help to under-
stand the pathogenesis of renal impairment caused by
hantavirus infection.
Conclusions
Acute kidney injury with massive proteinuria is a
hallmark of HFRS. The mechanisms of renal impair-
ment are not completely understood. Hantaviruses
PUUV and HTNV infect cells of the glomerular and
tubular apparatus. We showed that infection of renal
cells results in severe changes in the motility capacity.
Fig. 6 Effect of N protein expression on podocyte migration capacity. a Motility of podocytes transfected with plasmids encoding for maxGFP
and N protein of PUUV or HTNV was analyzed by live cell imaging eight hours after transfection. Cells transfected with pmaxGFP and empty vector
served as control (mock). Three independent experiments with 30 cells quantified in each experiment were performed. Shown is mean ± SD.
b Transfection efficiency and co-expression of maxGFP and N proteins were monitored by immunostaining for hantaviral N proteins (red). Mean
expression level of N proteins was determined by analysis of fluorescence intensity of N protein immunostaining in transfected podocytes. Cells were
imaged at a magnification of × 400
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Furthermore, our results demonstrate an important
role of hantaviral N protein in these effects. The
identification of N protein as a pathogenicity factor
provides useful insights in the possible mechanism of
proteinuria in HFRS.
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